Interaction of giant phospholipid vesicles containing cardiolipin and cholesterol with β2-glycoprotein-I and anti-β2-glycoprotein-I antibodies

Autoimmunity Reviews

Volumn 6, Issue 1, 2006, Pages 10-15

  Ambrožič, Aleš ^a   Čučnik, Saša ^a   Tomšič, Nejc ^b   Urbanija, Jasna ^b   Lokar, Maruša ^b   Babnik, Blaz ^b   Rozman, Blaž ^a   Iglič, Aleš ^b   Kralj Iglič, Veronika ^b,c  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

^c Nomadic College C/Berlanger   (Belgium)

Author keywords

2 glycoprotein I; Anti 2 glycoprotein I antibodies; Giant phospholipid vesicles

Indexed keywords

BETA2 GLYCOPROTEIN 1; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN; CHOLESTEROL; IMMUNOGLOBULIN G; PHOSPHOLIPID;

ANTIPHOSPHOLIPID SYNDROME; BLOOD CLOTTING; ELECTRICITY; HUMAN; IN VITRO STUDY; MORBIDITY; MORPHOLOGY; PHOSPHOLIPID VESICLE; PLASMA PROTEIN BINDING; PREGNANCY; REVIEW; THROMBOSIS;

ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; CARDIOLIPINS; CHOLESTEROL; HUMANS; IMMUNOGLOBULIN G;

EID: 33751218588     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2006.03.001     Document Type: Review

References (14)

1. Wilson W.A., Gharavi A.E., Koike T., Lockshin M.D., Branch W.D., Piette J.C., et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum 42/7 (1999) 1309-1311
2. Matsuura E., Igarashi Y., Fujimoto M., Ichikawa K., Suzuki T., Sumida T., et al. Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. J Immunol 148 (1992) 3885-3891
3. Roubey R.A.S. Antiphospholipid syndrome: antibodies and antigens. Curr Opin Hematol 7 (2000) 316-320
4. Ambrožič A., Božič B., Kveder T., Majhenc J., Arrigler V., Svetina S., et al. Budding, vesiculation and permeabilization of phospholipid membranes - evidence for a feasible physiologic role of beta2-glycoprotein I and pathogenic actions of anti-beta2-glycoprotein I antibodies. Biochim Biophys Acta 1740 (2005) 38-44
5. Tomšič N., Babnik B., Lombardo D., Mavčič B., Kandušer M., Iglič A., and Kralj-Iglič V. Shape and size of giant unilamellar phospholipid vesicles containing cardiolipin. J Chem Inf Model 45 (2005) 1676-1679
6. McNally T., MacKie I.J., Isenberg D.A., and Machin S.J. Immunoelectrophoresis and ELISA techniques for assay of plasma beta 2 glycoprotein-I and the influence of plasma lipids. Thromb Res 72 (1993) 275-286
7. Polz E., and Kostner G.M. The binding of beta 2-glycoprotein-I to human serum lipoproteins: distribution among density fractions. FEBS Lett 102 (1979) 183-186
8. Ambrožič A., Avčin T., Ichikawa K., Kveder T., Matsuura E., Hojnik M., et al. Anti-beta(2)-glycoprotein I antibodies in children with atopic dermatitis. Int Immunol 14 (2002) 823-830
9. Ambrožič A., Božič B., Hojnik M., Kveder T., and Rozman B. Antiphospholipid antibodies and rheumatoid arthritis. Ann Rheum Dis 61 (2002) 85-86
10. Angelova M.I., Soléau S., Meléard P., Faucon J.F., and Bothorel P. Preparation of giant vesicles by external AC electric fields. Kinetics and applications. Prog Colloid Polym Sci 89 (1992) 127-131
11. Bouma B., De Groot P.G., van den Elsen J.M., Ravelli R.B., Schouten A., Simmelink M.J., et al. Adhesion mechanism of human beta(2)-glycoprotein I to phospholipids based on its crystal structure. EMBO J 18 (1999) 5166-5174
12. Kralj-Iglič V., Iglič A., Gomišček G., Sevšek F., Arrigler V., and Hagerstrand H. Microtubes and nanotubes of a phospholipid bilayer membrane. J Phys A Math Gen 35 (2002) 1533-1549
13. Schlame M., Rue D., and Greenberg M.L. The biosynthesis and functional role of cardiolipin. Prog Lipid Res 39 (2000) 257-288
14. Schmid-Schonbein H., and Volger E. Red-cell aggregation and red-cell deformability in diabetes. Diabetes 25 (1976) 897-902